Hon Hai Precision Industry Co (鴻海精密) has invested in local cell-tissue banking and cell therapy company Bionet Corp (訊聯生物科技) through the purchase of NT$100 million (US$2.86 million) in Bionet shares, a Bionet official said.
The purchased shares represent 8.6 percent of Bionet’s outstanding shares, Bionet chairman Chris Tsai (蔡政憲) said at a media briefing yesterday.
The two companies plan to invest an additional NT$200 million in a joint venture called Conn Lian (康聯生醫), aimed at developing next-generation health care focused on predictive, preventive, personalized and participatory medicine, Tsai said.
Bolstered by the announcement, Bionet stocks rose limit-up to NT$43.40 on the GRETAI Securities Market. Hon Hai shares rose 5.01 percent to NT$75.5 on the Taiwan Stock Exchange.
Hon Hai’s latest announcement followed the signing on Wednesday of a global GreenCert agreement with IBM, Enterprise Information Management Inc and C-Lock Technology Inc. The companies will jointly introduce greenhouse gas emission measurement technology.
“Hon Hai will take 50 percent ownership of the newly formed company, while Bionet and the rest of the investment consortium will each take 22.5 percent and 27.5 percent,” Tsai said.
Tsai said that in order for Bionet to increase its scale of operations, it urgently needed sizable funding and a partner who understands the importance of biotechnology.
Bionet therefore approached Hon Hai as a first choice investment partner roughly one year ago, Tsai said.
“After consulting with numerous international biotechnology firms, Hon Hai has chosen to invest in Bionet due to its superior technology management and operational capabilities. This collaboration marks the nation’s first real step by a large conglomerate to actively invest in genetic engineering and stem cell research,” David Wu (吳啟誠), head of Hon Hai medical group, said at the same briefing.
In separate news, Wu said Hon Hai chairman Terry Gou (郭台銘) and his wife were both well and anticipated the arrival of their first baby sometime in May.
The domestic unit of the Chinese-owned, Dutch-headquartered chipmaker Nexperia BV will soon be able to produce semiconductors locally within China, according to two company sources. Nexperia is at the center of a global tug-of-war over critical semiconductor technology, with a Dutch court in February ordering a probe into alleged mismanagement at the company. The geopolitical tussle has disrupted supply chains, with some carmakers reportedly forced to cut production due to chip shortages. Local production would allow Nexperia’s domestic arm, Nexperia Semiconductors (China) Ltd (安世半導體中國), to bypass restrictions in place since October on the supply of silicon wafers — etched with tiny components to
Taiwan’s foreign exchange reserves fell below the US$600 billion mark at the end of last month, with the central bank reporting a total of US$596.89 billion — a decline of US$8.6 billion from February — ending a three-month streak of increases. The central bank attributed the drop to a combination of factors such as outflows by foreign institutional investors, currency fluctuations and its own market interventions. “The large-scale outflows disrupted the balance of supply and demand in the foreign exchange market, prompting the central bank to intervene repeatedly by selling US dollars to stabilize the local currency,” Department of Foreign
Taiwan is open to joining a global liquefied natural gas (LNG) program if one is created, but on the condition that countries provide delivery even in a scenario where there is a conflict with China, an energy department official said yesterday. While Taiwan’s priority is to have enough LNG at home, the nation is open to exploring potential strategic reserves in other countries such as Japan or South Korea, Energy Administration Deputy Director-General Chen Chung-hsien (陳崇憲) said. While the LNG market does not have a global reserve for emergencies like that of oil, the concept has been raised a few times —
AI-FUELED DEMAND: The company has been benefiting from the skyrocketing prices for DRAM chips amid the AI frenzy, especially its core product — DDR4 DRAM chips DRAM chipmaker Nanya Technology Corp (南亞科技) yesterday reported that its revenue for the first quarter surged 582.91 percent to NT$49.09 billion (US$1.54 billion) from NT$7.19 billion a year earlier, as the supply crunch caused chip price spikes. Last quarter’s figure is the highest on record. On a quarterly basis, revenue jumped 63.14 percent from NT$30.09 billion, the company said. In January, Nanya Technology expected global DRAM supply scarcity to continue through the first half of 2028, thanks to strong demand for artificial intelligence (AI) applications. Market researcher TrendForce Corp (集邦科技) forecast prices of standard DRAM chips would rise between 58 percent and 63
RSS